ZA200900626B - 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication - Google Patents
4-amino-4-oxobutanoyl peptides as inhibitors of viral replicationInfo
- Publication number
- ZA200900626B ZA200900626B ZA200900626A ZA200900626A ZA200900626B ZA 200900626 B ZA200900626 B ZA 200900626B ZA 200900626 A ZA200900626 A ZA 200900626A ZA 200900626 A ZA200900626 A ZA 200900626A ZA 200900626 B ZA200900626 B ZA 200900626B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitors
- amino
- viral replication
- oxobutanoyl peptides
- oxobutanoyl
- Prior art date
Links
- -1 4-amino-4-oxobutanoyl Chemical group 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000029812 viral genome replication Effects 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83048806P | 2006-07-13 | 2006-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200900626B true ZA200900626B (en) | 2010-04-28 |
Family
ID=40977667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200900626A ZA200900626B (en) | 2006-07-13 | 2009-01-27 | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101506223B (en) |
| SI (1) | SI2041156T1 (en) |
| UA (1) | UA101468C2 (en) |
| ZA (1) | ZA200900626B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS55123B1 (en) * | 2011-05-27 | 2016-12-30 | Achillion Pharmaceuticals Inc | Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections |
| CN102807607B (en) * | 2011-07-22 | 2013-10-23 | 爱博新药研发(上海)有限公司 | Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound |
| AU2014236502A1 (en) * | 2013-03-14 | 2015-10-01 | Achillion Pharmaceuticals, Inc. | Processes for producing Sovaprevir |
| EP2968171A1 (en) * | 2013-03-15 | 2016-01-20 | Achillion Pharmaceuticals, Inc. | Sovaprevir tablets |
| AR106018A1 (en) * | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS |
| WO2017035409A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders |
| WO2018160892A1 (en) | 2017-03-01 | 2018-09-07 | Achillion Pharmaceuticals, Inc. | Macrocyclic compounds for treatment of medical disorders |
| BR112021003660A2 (en) * | 2018-08-30 | 2021-05-18 | Albert Einstein College Of Medicine | compounds useful as modulators of chaperone-mediated autophagy |
| EP3898617A4 (en) | 2018-12-17 | 2022-08-17 | Achillion Pharmaceuticals, Inc. | TARGETED DOSING FOR THE TREATMENT OF COMPLEMENT-MEDIED DISORDERS |
-
2007
- 2007-07-13 UA UAA200901008A patent/UA101468C2/en unknown
- 2007-07-13 CN CN200780026271.2A patent/CN101506223B/en not_active Expired - Fee Related
- 2007-07-13 SI SI200731418T patent/SI2041156T1/en unknown
-
2009
- 2009-01-27 ZA ZA200900626A patent/ZA200900626B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2041156T1 (en) | 2014-04-30 |
| UA101468C2 (en) | 2013-04-10 |
| CN101506223B (en) | 2013-05-22 |
| CN101506223A (en) | 2009-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL214832A0 (en) | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
| IL212786A (en) | 4-amino- 4-oxobutanoyl peptides as inhibitors of viral replication | |
| ZA200907858B (en) | Novel peptide inhibitors of hepatitis c virus replication | |
| EP2190858A4 (en) | Urea-containing peptides as inhibitors of viral replication | |
| ZA200808022B (en) | Inhibitors of human immunodeficiency virus replication | |
| ZA201003283B (en) | Inhibitors of human immunodeficiency virus replication | |
| IL205746A0 (en) | Inhibitors of human immunodeficiency virus replication | |
| PL2220076T3 (en) | Inhibitors of human immunodeficiency virus replication | |
| GB0608899D0 (en) | Novel viral replication inhibitors | |
| EP2026843A4 (en) | Therapeutic uses of inhibitors of rtp801l | |
| GB0908394D0 (en) | Novel viral replication inhibitors | |
| GB0913636D0 (en) | Novel viral replication inhibitors | |
| SI2094702T1 (en) | Viral inhibitors | |
| ZA200900626B (en) | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
| GB0714649D0 (en) | Novel viral replication inhibitors | |
| ZA201104381B (en) | New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
| GB0621720D0 (en) | Inhibitors of ikk- serine-threonine protein kinase | |
| GB0607599D0 (en) | Novel Viral Replication Inhibitors | |
| HK1144232A (en) | Novel peptide inhibitors of hepatitis c virus replication | |
| GB0801939D0 (en) | Peptide inhibitors of lentiviral replication | |
| HK1122014A (en) | Inhibitors of viral replication | |
| HK1128280A (en) | Novel inhibitors of hepatitis c virus replication | |
| AU2006906693A0 (en) | Viral inhibitors | |
| HK1135396A (en) | Viral inhibitors | |
| GB0625381D0 (en) | Novel inhibitors of flaviridae |